Emerging roles for microRNAs in diabetic microvascular disease: Novel targets for therapy

Yu Zhang, Xinghui Sun, Basak Icli, Mark W. Feinberg

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

Chronic, low-grade systemic inflammation and impaired microvascular function are critical hallmarks in the development of insulin resistance. Accordingly, insulin resistance is a major risk factor for type 2 diabetes and cardiovascular disease. Accumulating studies demonstrate that restoration of impaired function of the diabetic macro- and microvasculature may ameliorate a range of cardiovascular disease states and diabetes-associated complications. In this review, we focus on the emerging role of microRNAs (miRNAs), noncoding RNAs that finetune target gene expression and signaling pathways, in insulin-responsive tissues and cell types important for maintaining optimal vascular homeostasis and preventing the sequelae of diabetes-induced end organ injury.We highlight current pathophysiological paradigms of miRNAs and their targets involved in regulating the diabetic microvasculature in a range of diabetes-associated complications such as retinopathy, nephropathy, wound healing, and myocardial injury. Weprovide an update of the potential use of circulatingmiRNAs diagnostically in type I or type II diabetes. Finally, we discuss emerging delivery platforms for manipulating miRNA expression or function as the next frontier in therapeutic intervention to improve diabetes-associated microvascular dysfunction and its attendant clinical consequences.

Original languageEnglish (US)
Pages (from-to)145-168
Number of pages24
JournalEndocrine reviews
Volume38
Issue number2
DOIs
StatePublished - Jan 1 2017

Fingerprint

MicroRNAs
Diabetes Complications
Microvessels
Type 2 Diabetes Mellitus
Insulin Resistance
Cardiovascular Diseases
Untranslated RNA
Wounds and Injuries
Wound Healing
Blood Vessels
Homeostasis
Therapeutics
Insulin
Inflammation
Gene Expression

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Emerging roles for microRNAs in diabetic microvascular disease : Novel targets for therapy. / Zhang, Yu; Sun, Xinghui; Icli, Basak; Feinberg, Mark W.

In: Endocrine reviews, Vol. 38, No. 2, 01.01.2017, p. 145-168.

Research output: Contribution to journalReview article

Zhang, Yu ; Sun, Xinghui ; Icli, Basak ; Feinberg, Mark W. / Emerging roles for microRNAs in diabetic microvascular disease : Novel targets for therapy. In: Endocrine reviews. 2017 ; Vol. 38, No. 2. pp. 145-168.
@article{1c9256fec53549178b866fa618c63be8,
title = "Emerging roles for microRNAs in diabetic microvascular disease: Novel targets for therapy",
abstract = "Chronic, low-grade systemic inflammation and impaired microvascular function are critical hallmarks in the development of insulin resistance. Accordingly, insulin resistance is a major risk factor for type 2 diabetes and cardiovascular disease. Accumulating studies demonstrate that restoration of impaired function of the diabetic macro- and microvasculature may ameliorate a range of cardiovascular disease states and diabetes-associated complications. In this review, we focus on the emerging role of microRNAs (miRNAs), noncoding RNAs that finetune target gene expression and signaling pathways, in insulin-responsive tissues and cell types important for maintaining optimal vascular homeostasis and preventing the sequelae of diabetes-induced end organ injury.We highlight current pathophysiological paradigms of miRNAs and their targets involved in regulating the diabetic microvasculature in a range of diabetes-associated complications such as retinopathy, nephropathy, wound healing, and myocardial injury. Weprovide an update of the potential use of circulatingmiRNAs diagnostically in type I or type II diabetes. Finally, we discuss emerging delivery platforms for manipulating miRNA expression or function as the next frontier in therapeutic intervention to improve diabetes-associated microvascular dysfunction and its attendant clinical consequences.",
author = "Yu Zhang and Xinghui Sun and Basak Icli and Feinberg, {Mark W.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1210/er.2016-1122",
language = "English (US)",
volume = "38",
pages = "145--168",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Emerging roles for microRNAs in diabetic microvascular disease

T2 - Novel targets for therapy

AU - Zhang, Yu

AU - Sun, Xinghui

AU - Icli, Basak

AU - Feinberg, Mark W.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Chronic, low-grade systemic inflammation and impaired microvascular function are critical hallmarks in the development of insulin resistance. Accordingly, insulin resistance is a major risk factor for type 2 diabetes and cardiovascular disease. Accumulating studies demonstrate that restoration of impaired function of the diabetic macro- and microvasculature may ameliorate a range of cardiovascular disease states and diabetes-associated complications. In this review, we focus on the emerging role of microRNAs (miRNAs), noncoding RNAs that finetune target gene expression and signaling pathways, in insulin-responsive tissues and cell types important for maintaining optimal vascular homeostasis and preventing the sequelae of diabetes-induced end organ injury.We highlight current pathophysiological paradigms of miRNAs and their targets involved in regulating the diabetic microvasculature in a range of diabetes-associated complications such as retinopathy, nephropathy, wound healing, and myocardial injury. Weprovide an update of the potential use of circulatingmiRNAs diagnostically in type I or type II diabetes. Finally, we discuss emerging delivery platforms for manipulating miRNA expression or function as the next frontier in therapeutic intervention to improve diabetes-associated microvascular dysfunction and its attendant clinical consequences.

AB - Chronic, low-grade systemic inflammation and impaired microvascular function are critical hallmarks in the development of insulin resistance. Accordingly, insulin resistance is a major risk factor for type 2 diabetes and cardiovascular disease. Accumulating studies demonstrate that restoration of impaired function of the diabetic macro- and microvasculature may ameliorate a range of cardiovascular disease states and diabetes-associated complications. In this review, we focus on the emerging role of microRNAs (miRNAs), noncoding RNAs that finetune target gene expression and signaling pathways, in insulin-responsive tissues and cell types important for maintaining optimal vascular homeostasis and preventing the sequelae of diabetes-induced end organ injury.We highlight current pathophysiological paradigms of miRNAs and their targets involved in regulating the diabetic microvasculature in a range of diabetes-associated complications such as retinopathy, nephropathy, wound healing, and myocardial injury. Weprovide an update of the potential use of circulatingmiRNAs diagnostically in type I or type II diabetes. Finally, we discuss emerging delivery platforms for manipulating miRNA expression or function as the next frontier in therapeutic intervention to improve diabetes-associated microvascular dysfunction and its attendant clinical consequences.

UR - http://www.scopus.com/inward/record.url?scp=85018178667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018178667&partnerID=8YFLogxK

U2 - 10.1210/er.2016-1122

DO - 10.1210/er.2016-1122

M3 - Review article

C2 - 28323921

AN - SCOPUS:85018178667

VL - 38

SP - 145

EP - 168

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 2

ER -